$31.56
1.58% yesterday
Nasdaq, Sep 27, 10:00 pm CET
ISIN
US8292141053
Symbol
SLP

Simulations Plus, Inc. Stock price

$31.56
-5.05 13.79% 1M
-9.79 23.68% 6M
-13.19 29.47% YTD
-9.38 22.91% 1Y
-7.66 19.53% 3Y
-2.46 7.23% 5Y
+24.80 366.86% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
+0.49 1.58%
ISIN
US8292141053
Symbol
SLP

Key metrics

Market capitalization $621.64m
Enterprise Value $503.59m
P/E (TTM) P/E ratio 65.47
EV/FCF (TTM) EV/FCF 36.05
EV/Sales (TTM) EV/Sales 7.52
P/S ratio (TTM) P/S ratio 9.28
P/B ratio (TTM) P/B ratio 3.44
Dividend yield 0.77%
Last dividend (FY24) $0.24
Revenue growth (TTM) Revenue growth 20.29%
Revenue (TTM) Revenue $66.98m
EBIT (operating result TTM) EBIT $7.00m
Free Cash Flow (TTM) Free Cash Flow $13.97m
Cash position $118.97m
EPS (TTM) EPS $0.47
P/E forward 66.11
P/S forward 8.74
EV/Sales forward 7.08
Short interest 10.75%
Show more

Is Simulations Plus, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Simulations Plus, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Simulations Plus, Inc. forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a Simulations Plus, Inc. forecast:

Buy
83%
Hold
17%

Financial data from Simulations Plus, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
May '24
+/-
%
67 67
20% 20%
100%
- Direct Costs 18 18
68% 68%
27%
49 49
9% 9%
73%
- Selling and Administrative Expenses 32 32
20% 20%
48%
- Research and Development Expense 4.91 4.91
17% 17%
7%
11 11
16% 16%
17%
- Depreciation and Amortization 4.50 4.50
23% 23%
7%
EBIT (Operating Income) EBIT 7 7
31% 31%
10%
Net Profit 9.65 9.65
7% 7%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Simulations Plus, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Simulations Plus, Inc. Stock News

Neutral
Business Wire
about one month ago
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus CEO, Shawn O'Connor, will be participating in Morgan Stanley's Global Healthcare Conference on September 6, 2024, in New York City.
Neutral
Business Wire
about one month ago
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced strategic changes in leadership and the structure of its business units to optimize operations and support future growth.
Neutral
Business Wire
2 months ago
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus CEO, Shawn O'Connor, will be presenting at KeyBanc's 25th Annual Technology Leadership Forum in Vail, CO, on Monday, August 5, 2024.
More Simulations Plus, Inc. News

Company Profile

Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.

Head office United States
CEO Shawn O'Connor
Employees 197
Founded 1996
Website www.simulations-plus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today